BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8603153)

  • 1. The role of antibiotics in the treatment of periodontitis (Part 2--Controlled drug delivery).
    Needleman IG; Pandya NV; Smith SR; Foyle DM
    Eur J Prosthodont Restor Dent; 1995 Mar; 3(3):111-7. PubMed ID: 8603153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local antimicrobial therapies in periodontal disease.
    Kinane DF
    Ann R Australas Coll Dent Surg; 2000 Oct; 15():57-60. PubMed ID: 11709978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of antibiotics in the treatment of periodontitis. (Part I--Systemic delivery.
    Smith SR; Foyle DM; Needleman IG; Pandya NV
    Eur J Prosthodont Restor Dent; 1994 Dec; 3(2):79-86. PubMed ID: 8605507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled local delivery of antimicrobials in the treatment of periodontitis.
    Killoy WJ; Polson AM
    Dent Clin North Am; 1998 Apr; 42(2):263-83. PubMed ID: 9597337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapocket tetracycline release in periodontal therapy.
    Donley TG; Pearlstein ME
    Gen Dent; 1993; 41(1):61-5; quiz 67-8. PubMed ID: 7489866
    [No Abstract]   [Full Text] [Related]  

  • 6. Local delivery of antimicrobial agents for the treatment of periodontitis.
    Magnusson I
    Compend Contin Educ Dent; 1998 Oct; 19(10):953-6; 958, 960 passim quiz 966. PubMed ID: 10371879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles and clinical applications of periodontal controlled drug delivery with tetracycline fibers.
    Tonetti MS; Pini-Prato G; Cortellini P
    Int J Periodontics Restorative Dent; 1994 Oct; 14(5):421-35. PubMed ID: 7751109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled local delivery of tetracycline in the treatment of periodontitis.
    Killoy WJ; Cobb CM
    Compendium; 1992 Dec; 13(12):1150, 1152, 1154 passim. PubMed ID: 1298560
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled-delivery chlorhexidine chip versus amoxicillin/metronidazole as adjunctive antimicrobial therapy for generalized aggressive periodontitis: a randomized controlled clinical trial.
    Kaner D; Bernimoulin JP; Hopfenmüller W; Kleber BM; Friedmann A
    J Clin Periodontol; 2007 Oct; 34(10):880-91. PubMed ID: 17850607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supportive periodontal therapy using mechanical instrumentation or 2% minocycline gel: a 12 month randomized, controlled, single masked pilot study.
    McColl E; Patel K; Dahlen G; Tonetti M; Graziani F; Suvan J; Laurell L
    J Clin Periodontol; 2006 Feb; 33(2):141-50. PubMed ID: 16441740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of controlled-release delivery systems for chemotherapeutic agents in periodontics.
    Fiorellini JP; Paquette DW
    Curr Opin Dent; 1992 Mar; 2():63-79. PubMed ID: 1520942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical look at the subject of fees.
    Flanagan D
    Dent Econ; 1996 Feb; 86(2):41-7. PubMed ID: 9020636
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of chronic periodontitis: a site-specific fiber placement technique.
    Anderson HH
    Pract Periodontics Aesthet Dent; 1996 Aug; 8(6):565-70; quiz 572. PubMed ID: 9242124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of controlled drug delivery for periodontitis. The Research, Science and Therapy Committee of the American Academy of Periodontology.
    Greenstein G; Tonetti M
    J Periodontol; 2000 Jan; 71(1):125-40. PubMed ID: 10695948
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of tetracycline fibres in the treatment of generalised aggressive periodontitis: clinical and microbiological findings.
    Sakellari D; Vouros I; Konstantinidis A
    J Int Acad Periodontol; 2003 Apr; 5(2):52-60. PubMed ID: 12760507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance profile of the subgingival microbiota following systemic or local tetracycline therapy.
    Rodrigues RM; Gonçalves C; Souto R; Feres-Filho EJ; Uzeda M; Colombo AP
    J Clin Periodontol; 2004 Jun; 31(6):420-7. PubMed ID: 15142209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of local drug delivery in the management of periodontal diseases: a comprehensive review.
    Greenstein G; Polson A
    J Periodontol; 1998 May; 69(5):507-20. PubMed ID: 9623893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: role of controlled drug delivery for periodontitis (position paper). The American Academy of Periodontology (2000;71:12-40).
    Finkelman RD
    J Periodontol; 2000 Dec; 71(12):1929-33. PubMed ID: 11156051
    [No Abstract]   [Full Text] [Related]  

  • 19. [A biocompatibility study and the effects of slow-release antibiotic materials in the treatment of periodontal disease. II. The biocompatibility and behavior of polyhydroxyethyl methacrylate (pHEMA) as a slow-release material for tetracycline of metronidazole. A study of 2 cases].
    Aronna G; De Rosa A; Rosso F; Margarucci S; Caruso F
    Minerva Stomatol; 1998 Oct; 47(10):559-64. PubMed ID: 9866971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local drug delivery in the treatment of periodontitis.
    Stanford TW
    Tex Dent J; 2001 Oct; 118(10):978-83. PubMed ID: 11764629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.